Frazier Management as of Sept. 30, 2019
Portfolio Holdings for Frazier Management
Frazier Management holds 19 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 25.3 | $81M | 2.3M | 34.99 | |
| Mirum Pharmaceuticals (MIRM) | 11.2 | $36M | 3.6M | 10.06 | |
| Iovance Biotherapeutics (IOVA) | 10.0 | $32M | 1.8M | 18.20 | |
| Krystal Biotech (KRYS) | 9.7 | $31M | 895k | 34.73 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 6.8 | $22M | 1.9M | 11.48 | |
| Translate Bio | 6.8 | $22M | 2.2M | 9.91 | |
| Gritstone Oncology Ord (GRTSQ) | 5.6 | $18M | 2.1M | 8.63 | |
| Allena Pharmaceuticals | 4.1 | $13M | 3.3M | 3.94 | |
| Aptinyx | 3.5 | $11M | 3.2M | 3.49 | |
| Alpine Immune Sciences | 3.2 | $10M | 2.6M | 3.96 | |
| Millendo Therapeutics | 3.1 | $9.9M | 1.4M | 7.11 | |
| Iterum Therapeutics | 2.8 | $8.9M | 1.5M | 5.77 | |
| Nabriva Therapeutics | 2.7 | $8.5M | 4.3M | 2.00 | |
| Entasis Therapeutics Holdings Ord | 2.5 | $8.0M | 1.3M | 5.96 | |
| Sierra Oncology | 1.0 | $3.2M | 8.1M | 0.39 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $2.6M | 1.3M | 2.00 | |
| Kezar Life Sciences | 0.5 | $1.5M | 468k | 3.28 | |
| Bellicum Pharma | 0.3 | $1.1M | 1.1M | 1.05 | |
| Synlogic | 0.2 | $647k | 283k | 2.29 |
